Development in circulating tumor cells (CTCs) technologies represents a valuable tool for the better understanding of tumor biology. The clinical relevance of CTCs as a prognostic factor is well ...

Detection of circulating tumor cells (CTCs) in the blood of patients with CRPC might be of prognostic and predictive relevance and might complement or replace prostate-specific antigen (PSA ...